首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >Antihyperlipidemic and Antioxidative Potentials of Onion (Allium cepa L.) Extract Fermented with a Novel Lactobacillus casei HD-010
【2h】

Antihyperlipidemic and Antioxidative Potentials of Onion (Allium cepa L.) Extract Fermented with a Novel Lactobacillus casei HD-010

机译:新型干酪乳杆菌HD-010发酵的洋葱提取物的降血脂和抗氧化能力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study was to investigate antihyperlipidemic and antioxidative potentials of onion (Allium cepa L.) extract fermented with a novel Lactobacillus casei HD-010. In general, fermented onion extract is used for its antioxidative activity (ORAC), inhibitory effect on adipocytes differentiation, quercetin contents, and antihyperlipidemic activities. However, the effect of fermented onion extract on hyperlipidemia after oral administration using ApoE-deficient mice has not been reported yet. To understand the effect of fermented onion extract on hyperlipidemia, we used benzafibrate (10 mg/kg, bw/day) as a positive control in the present study. Serum was collected every week to analyze levels of low density lipoprotein (LDL), high density lipoprotein (HDL), triglyceride (TG), and cholesterol, 3-hydroxy-3-methylgutaryi-CoA (HMG-CoA) reductase activity, and cholesterol ester transport protein (CETP) activity. In the fermented onion-treated group, HDL level was significantly increased while levels of TG and LDL were significantly decreased compared to those in the control group. In addition, the inhibition activity of HMG-CoA reductase was increased 20% in the fermented onion-treated group at 100 mg/kg. CETP activity has been observed to be significantly inhibited in the fermented onion-treated groups compared to that in the control group. These results suggest that fermented onion has a preventive/therapeutic effect on hyperlipidemic disease. It might have potential to be developed as a functional food.
机译:本研究的目的是研究用新型干酪乳杆菌HD-010发酵的洋葱(洋葱Cepa L.)提取物的降血脂和抗氧化能力。通常,发酵洋葱提取物因其抗氧化活性(ORAC),对脂肪细胞分化的抑制作用,槲皮素含量和抗高血脂活性而被使用。然而,尚未报道使用ApoE缺陷型小鼠口服洋葱后发酵的洋葱提取物对高脂血症的作用。为了了解发酵的洋葱提取物对高脂血症的影响,我们在本研究中使用苯扎贝特(10 mg / kg,bw /天)作为阳性对照。每周收集一次血清,以分析低密度脂蛋白(LDL),高密度脂蛋白(HDL),甘油三酸酯(TG)和胆固醇,3-羟基-3-甲基古塔酰胺-CoA(HMG-CoA)还原酶活性和胆固醇的水平酯转运蛋白(CETP)活性。与对照组相比,在发酵洋葱处理组中,HDL水平显着升高,而TG和LDL水平显着降低。另外,在以100mg / kg进行发酵的洋葱处理组中,HMG-CoA还原酶的抑制活性增加了20%。与对照组相比,已观察到在经洋葱处理的发酵组中CETP活性受到显着抑制。这些结果表明,发酵洋葱对高脂血症具有预防/治疗作用。它可能有潜力被开发为功能食品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号